Using patients insights to move the industry forward

What we do
We work with one of the most important forces in healthcare: the Patient Movement.
PatientView undertakes regular evidence-based research into the different perspectives of patient organisations around the world on a range of issues. PatientView’s reach among these patient organisations is unique, with as many as 40,000 such groups in our informal network.
Patient organisations are in a unique position to provide valuable insights since they are the only stakeholder to interact across every aspect of the healthcare system: from regulators, physicians, healthcare providers, healthcare payers, and of course patients. Patient organisations hold strong views not only about the experiences and needs of patients with whom they are familiar, but on their country’s healthcare policies and systems, the value of technologies (including digital and mobile), and even the reputational status of the various agencies that make healthcare. Across our 20 year history, PatientView has collated evidence-based feedback on all these important subjects. Today, our most high-profile product concerns the corporate reputation of the pharmaceutical industry (from the perspective of patient groups). The product helps pharma develop and improve their strategies to build robust relationships with their ultimate customers, patients - and of course patient groups.
Latest News

ESG and Aerosol inhalers: can health systems use environmentally sustainable treatments and still be truly patient-centric?
August 2022: PatientView have released a first-of-its-kind report which reveals the patient perspective on the pharma industry and ESG. This blog shares one case study from the report and explores… Continue reading “ESG and Aerosol inhalers: can health systems use environmentally sustainable treatments and still be truly patient-centric?”

Patient groups provide a new perspective on Environmental, Social and Governance (ESG) policy within pharma
June 2022: New research published by PatientView shares how patient groups rank the pharma industry and individual companies by their ESG practices. A term created by the United Nations Global… Continue reading “Patient groups provide a new perspective on Environmental, Social and Governance (ESG) policy within pharma”
Latest report
Germany Edition: The Corporate Reputation of Pharma in 2021
PatientView's latest performance report of the pharmaceutical industry during 2021 collates the views and opinions of 151 German patient groups.
